Fact Sheet

CMS’s Part B Experiment Lacks Essential Patient Protections

CMS’s Part B Experiment

PhRMA April 29, 2016

The Center for Medicare & Medicaid Services’ (CMS) proposed Part B Drug Payment Model would make sweeping changes to Part B reimbursement that could put patient access and quality of care at risk. The proposed experiment would be mandatory for almost three-quarters of Medicare providers nationwide – one of the largest demonstrations ever proposed – and as a result could have significant unintended indirect consequences for Medicare beneficiaries.